Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal. - Wikidata - awgldk - TriplyDB

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

http://www.wikidata.org/entity/Q37782957

about

Role of cytochrome P450 in drug interactions Crystal structure of human cytochrome P450 2D6 Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system.Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.CYP2D6 polymorphisms in patients with porphyrias Pharmacogenetics: Part I.The role of pharmacogenetics in cancer therapeutics.Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.Fluoxetine bioequivalence study: quantification of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry.Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians.The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes Pharmacogenetics: part I: Perspective. 1992.Pharmacogenetics: part II: Perspective. 1992.PRN prescribing in psychiatric inpatients: potential for pharmacokinetic drug interactions.

P2860

Q21245066-9D43F089-9911-4F0A-A80F-C9B7AC251293 Q24298673-95BDEB1C-F131-450E-927E-D4E3E5CF3034 Q33630990-2507C737-6DCE-4D53-A036-91ADD6C66B89 Q33668831-FD862341-D273-4B5A-823D-00CD823D0A78 Q34403471-5B204273-24EC-48A4-B410-480136898CE2 Q35586929-59202314-6626-4C1D-B714-4C9C50EAF6CF Q36215632-095F1C50-2AE1-4F9B-8B3C-C668023AEE50 Q36536674-DC1C454B-A636-4FCD-8A2D-79EB97F0FE34 Q37975545-36E4E769-4C0C-4147-8019-BE16FD545867 Q40794329-7155F52E-D25A-4A4C-9616-3DBE8E7E5E09 Q41921463-2EC897B2-871F-4C6B-9885-F96A224836E0 Q42052107-7ABA6AFB-0038-42BB-B875-9FC274C35962 Q48543712-A0361277-26C2-4C7B-A6E4-2F46279C7D21 Q48543727-06CD524E-5163-44A0-82D8-44C630F1B49D Q51906451-451F975C-8B6B-490D-8B6F-3DFBEF4B21F9

P2860

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

http://www.wikidata.org/entity/Q37782957

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1990

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@en

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@nl

type

label

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@en

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@nl

prefLabel

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@en

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@nl

P1433

Q37782957-F8F57831-4E1C-41FC-A139-00994070290E

P1476

Q37782957-BB4883CE-8267-4374-8E34-70179410AB00

P2093

Q37782957-10FE2E37-6428-4C93-A737-A96BE352C86F

P2860

Q37782957-0A7A8CA5-B6F8-485C-97E4-437F87F2C7D1

Q37782957-0BB61622-D412-4DA3-B4A0-6096243F83B8

Q37782957-1AC5D7AE-C8B8-4DC7-A19B-F15C8AF57F59

Q37782957-24F64B03-D745-497D-84BD-BA69B19C8DAC

Q37782957-3786AB2D-894C-47F4-826E-5AB74C6D6DAE

Q37782957-428E8E29-6C9E-448A-B75E-3AACD8A1D510

Q37782957-43381CE6-78D9-45C3-8DAA-CE618FA812A4

Q37782957-4A339771-9FBD-4031-B9E7-A35F7CB0982C

Q37782957-4CC85410-0548-4A9A-B46F-A69B4D386989

Q37782957-4D7490CC-985A-410D-A80A-238AE4A4EF35

P304

Q37782957-8DE35E22-8EAC-4625-B77E-F17EC6889320

P31

Q37782957-C11FEC77-0ACB-4D12-BE94-93F2BD00EBD9

P356

Q37782957-82381528-E770-4CF3-9965-B414A6E339D2

P433

Q37782957-61F88206-95E6-4D67-8707-1DA5D6EBF97F

P478

Q37782957-2EC22876-0AC4-4462-B469-F00006D95341

P577

Q37782957-6528FB29-D699-4474-803D-B3A854F80E34

P5875

Q37782957-3B2A7F09-6AF6-47D6-A39F-3226A9D15B7E

P698

Q37782957-0CB1C3A1-3101-410F-8022-E957E9F32FA0

P356

J.1600-0773.1990.TB00830.X

P1433

Basic and Clinical Pharmacology and Toxicology

P1476

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.

@en

P2093

Lennard MS

http://www.w3.org/2001/XMLSchema#string

P2860

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--histograms and probit plots.

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing.

Variable metabolism of pinacidil: lack of correlation with the debrisoquine and trimethylamine C- and N-oxidative polymorphisms

Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.

Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.

Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development.

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

The effects of diabetes mellitus, exercise, and single doses of biguanides upon lactate metabolism in man

Debrisoquine oxidation in an Australian population.

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.

P304

273-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0773.1990.TB00830.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

1990-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21077547

http://www.w3.org/2001/XMLSchema#string

P698

2077517

http://www.w3.org/2001/XMLSchema#string